ライフサイエンスコーパス: cava

1 he site of obstruction and the inferior vena cava.

2 pposite trend was shown in the superior vena cava.

3 ter because of stenosis in the superior vena cava.

4 ral vein through the adjoining inferior vena cava.

5 4) and C57BL/6 mice (n = 5), using the vena cava.

6 on of the iliofemoral veins or inferior vena cava.

7 otein in TD compared with the aorta and vena cava.

8 al four chamber, and subcostal inferior vena cava.

9 of the right lung entering the superior vena cava.

10 arterioles, or ligation of the inferior vena cava.

11 left atrial appendage and the superior vena cava.

12 the right ventricular apex and superior vena cava.

13 r between the right atrium and superior vena cava.

14 g filter migration or thrombosis of the vena cava.

15 sequence, and persistent left superior vena cava.

16 ated and severed at the junction to the vena cava.

17 nalis, RA free wall, and right superior vena cava.

18 ide the coronary sinus via the superior vena cava.

19 ta, main pulmonary artery, and superior vena cava.

20 ial ligation (stenosis) of the inferior vena cava.

21 ased thrombus frequency in the inferior vena cava.

22 for cannulation of the swine aorta and vena cava.

23 0.10) and descending aorta and superior vena cava (0.14 L/min +/- 0.12).

24 ery=26, pulmonary vein=21, and superior vena cava=12).

25 cending aorta, 191 (121, 261); superior vena cava, 137 (77, 197); ductus arteriosus, 187 (109, 265);

26 (16/47, 34%), persistent left superior vena cava (14/47, 30%), and abnormal branching of the right p

27 7 +/- 2%), thorax (14 +/- 2%), inferior vena cava (23 +/- 2%) and liver (23 +/- 2%) (all P </= 0.005

28 ascending aorta, 41 (29, 53); superior vena cava, 29 (15, 43); ductus arteriosus, 41 (25, 57); desce

29 abnormality followed by double superior vena cava (9.78%).

30 s achieved by cannulating the aorta and vena cava after death.

31 phrenic nerve pacing from the superior vena cava, all patients underwent diaphragmatic electromyogra

32 planted by end-to-side aorta-aorta and porto-cava anastomoses and end-to-end colorectal anastomosis.

33 that most commonly affect the inferior vena cava and account for 5% of all leiomyosarcomas.

34 For the superior vena cava and brachiocephalic veins, the reconstructions at 1

35 PLD facilitates total hepatectomy with vena cava and caval flow preservation.

36 limited the evaluation of the inferior vena cava and common iliac veins near the confluence.

37 o the left subclavian vein and superior vena cava and evaluated for up to 90 minutes.

38 ve liver with narrow access to inferior vena cava and fragile venous wall may lead to venous tearing

39 e adrenal vein drainage to the inferior vena cava and hepatic vein or of the inferior phrenic vein (n

40 or treatment by evaluating the inferior vena cava and other cardiac structures.Lung ultrasound can no

41 est, large-vessel anastomosis (superior vena cava and pulmonary artery [PA] or bidirectional Glenn op

42 (>3 mm) apposition between the inferior vena cava and pulmonary venous atrium (cavoatrial overlap).

43 region of overlap between the inferior vena cava and pulmonary venous atrium is feasible.

44 ular balloon positioned at the superior vena cava and right atrial junction (SVC-RAJ) reduces sodium

45 r bolus dispersion in blood between the vena cava and the arterial tree was applied.

46 transformation that linked the superior vena cava and the coronary sinus from the CT model with a cat

47 cted from the hepatic vein and superior vena cava and underwent protein profiling for a panel of 20 a

48 Tumors invading the vena cava and/or the hepatocaval confluence are indications f

49 elet deposition in the ligated inferior vena cava, and diminished platelet activation in vitro.

50 t coronary artery (RCA) to the inferior vena cava, and from the RCA to the tricuspid valve annulus we

51 the abdomen, heart, chest, and inferior vena cava, and many variations in technique, protocols, and i

52 eptal defects, persistent left superior vena cava, and patent ductus arteriosus, were present in 32%

53 ced by flow restriction in the inferior vena cava, APP-KO mice, as well as chimeric mice with selecti

54 ed unequivocally in the murine inferior vena cava as hot spots in vivo by simultaneous acquisition of

55 cavity, left atrial cavity, or inferior vena cava as the IDIF.

56 was performed from within the inferior vena cava at areas of esophageal contact.

57 s a 17% difference in the image-derived vena cava blood activity at 60 min, compared with the ex vivo

58 0%), whereas 55% +/- 19 of the inferior vena cava blood flowed to the left PA (range, 22%-82%).

59 circulation, 87% +/- 13 of the superior vena cava blood flowed to the right PA (range, 63%-100%), whe

60 eta isoform expressed equally in TD and vena cava, both being approximately 2 times higher than that

61 ge of peak activity was observed in the vena cava, but the area under the curve over 2 min was simila

62 trograde flow, greatest in the superior vena cava.(C) RSNA, 2019Online supplemental material is avail

63 Superior vena cava catheterization interventions between August 1984 a

64 measures, pulse generator and superior vena cava coil location, and angle of lead exit from the pock

65 nce interval 0.65-0.89) or the inferior vena cava collapsibility index (area under the curve 0.66; 95

66 essure (R = 0.58), whereas the inferior vena cava collapsibility index and the internal jugular vein

67 s, with a significantly higher inferior vena cava collapsibility index on day 0 than nonacidotic pati

68 ntral venous pressure than the inferior vena cava collapsibility index or the internal jugular vein a

69 Inferior vena cava collapsibility index was not an independent predict

70 stroke volume index, and high inferior vena cava collapsibility index, which improved with subsequen

71 ontractility and assessment of inferior vena cava collapsibility.

72 nt a unique case, in which the inferior vena cava compression by a total artificial heart was initial

73 P < .01), particularly in the superior vena cava.ConclusionFour-dimensional flow MRI had good-to-exc

74 The CAVA (Continuous Ambulatory Vestibular Assessment) devic

75 ailable in 65 patients, as the inferior vena cava could not be visualized in two patients.

76 Transmural pressure of the superior vena cava decreased during inspiration, whereas the transmura

77 ween the right portal vein and inferior vena cava detected on postnatal ultrasound examination.

78 An inferior vena cava diameter < 2 cm predicted a central venous pressure

79 sure (< 10 mm Hg) was 0.91 for inferior vena cava diameter (95% confidence interval 0.84-0.98), which

80 sophageal echocardiography, of inferior vena cava diameter (IVC) measured using transthoracic echocar

81 1), respiratory variability of inferior vena cava diameter (r = 0.42; p < 0.01), and pulse pressure v

82 udy, respiratory variations of superior vena cava diameter (SVC) measured using transesophageal echoc

83 The maximal inferior vena cava diameter correlated moderately with central venous

84 s pressure after adjusting for inferior vena cava diameter in a multiple linear regression model.

85 sopressor support, the maximal inferior vena cava diameter is a more robust estimate of central venou

86 Respiratory variation in vena cava diameter measured by ultrasound (distensibility ind

87 The proximal mouse vena cava diameter was 2.54 +/- 0.30 mm.

88 idth ratio (aspect ratio), the inferior vena cava diameter, and the percent collapse of the inferior

89 al, respiratory variability of inferior vena cava diameter, or pulse pressure variation.

90 of the central isthmus (RCA to inferior vena cava distance).

91 Patients with less vena cava distensibility were not as likely to be fluid respo

92 he collapsibility index of the inferior vena cava during a deep standardized inspiration is a simple,

93 nto the grafts through the suprahepatic vena cava during cold storage (VSOP-NO group; n=20).

94 l expression pattern in mouse aorta vs. vena cava ECs, which cannot be explained by the difference in

95 n they become firmly embedded along the vena cava endothelium.

96 rombosis (A 0%, B 24%, C 76%), inferior vena cava filter (A 0%, B 31%, C 69%), and renal artery steno

97 Vena cava filter (VCF) placement for pulmonary embolism (PE)

98 Early prophylactic placement of a vena cava filter after major trauma did not result in a lower

99 Early placement of a vena cava filter did not result in a significantly lower inci

100 no placement of a filter (13.9% in the vena cava filter group and 14.4% in the control group; hazard

101 olism developed in none of those in the vena cava filter group and in 5 (14.7%) in the control group,

102 Among the 46 patients in the vena cava filter group and the 34 patients in the control gro

103 y were assigned to retrievable inferior vena cava filter implantation plus anticoagulation (filter gr

104 Insertion of a retrievable inferior vena cava filter in patients randomized to the filter group.

105 h a significant bleeding risk, inferior vena cava filter insertion compared with anticoagulant therap

106 sessed the association between inferior vena cava filter insertion for known significant bleeding ris

107 cal pulmonary embolectomy, and inferior vena cava filter insertion.

108 ation to anticoagulant agents to have a vena cava filter placed within the first 72 hours after admis

109 Trauma patients and inferior vena cava filter placements were excluded.

110 lism, the use of a retrievable inferior vena cava filter plus anticoagulation compared with anticoagu

111 Whether early placement of an inferior vena cava filter reduces the risk of pulmonary embolism or de

112 ombosis risk factors, avoiding inferior vena cava filter usage except in specified circumstances, avo

113 The effectiveness of inferior vena cava filter use among patients with acute symptomatic VT

114 (previous thromboembolism, preoperative vena cava filter, hypoventilation, pulmonary hypertension), a

115 in (29%), dalteparin (40%), or inferior vena cava filters (20%) were not statistically different (p =

116 Evidence that vena cava filters (VCFs) are beneficial is limited.

117 e in the society guidelines, the use of vena cava filters (VCFs) continues to rise.

118 Although retrievable inferior vena cava filters are frequently used in addition to anticoag

119 Limited evidence suggests that vena cava filters are only modestly efficacious for preventio

120 tions such as thrombolysis and inferior vena cava filters are reserved for limited circumstances.

121 o define prolonged retrievable inferior vena cava filters dwell time by determining the inflection po

122 However, mechanical approaches such as vena cava filters have high complication and treatment failur

123 ecent trial data do not support insertion of cava filters in patients who can receive anticoagulant t

124 tigate the survival effects of inferior vena cava filters in patients with venous thromboembolism (VT

125 Patients with retrievable inferior vena cava filters in place beyond 7 months may benefit from r

126 Although chronically implanted inferior vena cava filters may result in filter-related morbidity, the

127 rm the management of fractured inferior vena cava filters on the basis of results from a tertiary ref

128 effective in removing embedded inferior vena cava filters refractory to standard retrieval and high f

129 Superior vena cava filters should be avoided.

130 l further data emerge, thrombolysis and vena cava filters should be reserved for patients in whom ant

131 Inferior vena cava filters were placed in 46%.

132 acted retrieval of retrievable inferior vena cava filters with prolonged dwell times; however, there

133 eding tube placement, tracheostomy, and vena cava filters) among nursing home residents to rates amon

134 icacy of thrombolytic therapy, inferior vena cava filters, and embolectomy during pregnancy.

135 best reserved for severe VTE; inferior vena cava filters, ideally the retrievable variety, should be

136 th in placement of retrievable inferior vena cava filters, retrieval rates remain low.

137 iminished by leg compression devices or vena cava filters.

138 w were performed by increasing inferior vena cava flow.

139 fibrillation triggered from a superior vena cava focus (1 patient) adjacent to the right PN or epica

140 ism (five of 23; 22%), and the inferior vena cava (four of 23; 17%).

141 stomosis of liver allograft to a Dacron vena cava graft can be a feasible solution if traditional ana

142 o the level of cortisol in the inferior vena cava >= 5.

143 index of collapsibility of the superior vena cava>/=36%), inotropic support (left ventricular fractio

144 sis created by ligation of the inferior vena cava, HO-1 expression is markedly induced.

145 Following ligation of the inferior vena cava, HO-1(-/-) mice exhibited increased nuclear factor

146 r; n = 7) or infusion into the inferior vena cava (Humulin R; n = 6) using an algorithm to match plas

147 Vena cava IDIF (n = 7) was compared with the left ventricular

148 acute insulin treatment, using a mouse vena cava IDIF approach.

149 The mouse vena cava IDIF provides repeatable assessment of the blood ti

150 l glucose uptake rates (rMGU) using the vena cava IDIF were calculated at baseline (n = 8), after ind

151 s was systematically assessed using the vena cava image-derived blood input function (IDIF).

152 idney, brain, lung, vitreous humor, and vena cava in comparison to untreated controls (P </= .05).

153 eased net and peak flow in the inferior vena cava in end inspiration compared with end expiration, an

154 lation and improve exposure of inferior vena cava in patients with massive hepatomegaly related to PL

155 tissues, such as the aorta and inferior vena cava, in which Mypt1 E23 is predominately skipped.

156 ce of superior mesenteric artery (SMA), vena cava inferior confluence (CVC), abdominal aorta bifurcat

157 mbosis induced by flow reduction in the vena cava inferior, we identified blood-derived high-mobility

158 try and flow rates through the superior vena cava, inferior vena cava, left pulmonary artery, and rig

159 We hypothesize that inferior vena cava-inferior atrial ganglionated plexus nerve activity

160 adable TEVGs were implanted as inferior vena cava interposition conduits in 2 groups of C57BL/6 mice

161 t were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice.

162 e therapeutic modalities (thrombolysis, vena cava interruption, venous stenting).

163 Persistent left superior vena cava is a rare but important congenital vascular anomaly

164 ionally, the transmural pressure of the vena cava is decreased, whereas the transmural pressure of th

165 ygen saturation (ScvO2) in the superior vena cava is predominantly determined by cardiac output, arte

166 thrombectomy even when cross-clamping of the cava is required.

167 Adjunctive ablation included superior vena cava isolation in 6 patients, cavotricuspid isthmus abla

168 atment of chronic occlusion of inferior vena cava (IVC) and iliocaval confluence with angioplasty and

169 incidental finding of complete inferior vena cava (IVC) and obliteration.

170 e IPVE, and using the aorta or inferior vena cava (IVC) as the input function.

171 ide diameters of the aorta and inferior vena cava (IVC) at the top of L2 and the bottom of L4 and to

172 ailure to remove a retrievable inferior vena cava (IVC) filter can cause severe complications with hi

173 implantation of an absorbable inferior vena cava (IVC) filter in a swine model.

174 ping heparin and warfarin, and inferior vena cava (IVC) filter placement were not independent predict

175 ationship between prophylactic inferior vena cava (IVC) filter use, mortality, and VTE.

176 Inferior vena cava (IVC) filters are widely used for prevention of pul

177 The use of inferior vena cava (IVC) filters for prevention of venous thromboembol

178 The use of inferior vena cava (IVC) filters in this population has been increasin

179 ed on the role of prophylactic inferior vena cava (IVC) filters to prevent PE.

180 studies concerning the use of inferior vena cava (IVC) filters.

181 ded control) were implanted as inferior vena cava (IVC) interposition grafts in juvenile lambs.

182 Obstruction of the inferior vena cava (IVC) is infrequent, membranous obstruction of the

183 rothrombotic propensity in the inferior vena cava (IVC) ligation model.

184 ophil-rich clots after partial inferior vena cava (IVC) ligation than those that formed in wild-type

185 littermates underwent partial inferior vena cava (IVC) ligation to induce venous thrombosis.

186 ents of the venous flow in the inferior vena cava (IVC) of 14 Fontan patients and 11 normal controls

187 8-hour flow restriction in the inferior vena cava (IVC) results in the development of thrombi structu

188 e, using a murine DVT model of inferior vena cava (IVC) stenosis, we demonstrate that mice with gener

189 Inferior vena cava (IVC) thrombosis is generally a contraindication to

190 chronic iliofemoral (I-F) and inferior vena cava (IVC) thrombosis.

191 associated with renal vein or inferior vena cava (IVC) thrombus in up to 10% of cases.

192 been suggested for the use of inferior vena cava (IVC) value instead of FHVP to calculate HVPG when

193 of the hepatic segment of the inferior vena cava (IVC) were the vascular anomalies.

194 profile of the mouse aorta and inferior vena cava (IVC), not restricting our analysis to the endothel

195 tumors with extension into the inferior vena cava (IVC).

196 infrahepatic and suprahepatic inferior vena cava (IVC).

197 hrough the superior vena cava, inferior vena cava, left pulmonary artery, and right pulmonary artery.

198 Baseline renal vein and inferior vena cava levels of inflammatory markers were measured and th

199 ity to venous thrombosis after inferior vena cava ligation at 12 or 18 months of age (P<0.05 versus 4

200 on thrombosis were examined by inferior vena cava ligation in congenic mice with and without alpha2-a

201 nous thrombosis was induced by inferior vena cava ligation in mice with genetic deletion of TGFbeta1

202 ease the theoretical risk of a positive vena cava margin or hematologic metastases.

203 of the mesentericoportal vein (n = 24), vena cava (n = 3), or hepatic vein (n = 3).

204 Inferior vena cava occlusion at all experimental stages (baseline, dob

205 orary preload reduction during inferior vena cava occlusion initially induced an expansion of LV end-

206 vena cava thrombosis, chronic inferior vena cava occlusion, and pain from retroperitoneal or bowel p

207 oop data obtained during acute inferior vena cava occlusion.

208 Venous thrombosis was induced in the vena cava of BALB/C mice, and temporal changes in T1 relaxati

209 thrombosis was induced in the inferior vena cava of male BALB/C mice.

210 atelet microparticles into the inferior vena cava of mice and harvested endothelial cells from the pu

211 ered in 4 and 1 swine from the inferior vena cava onto a forcefully deviated esophagus.

212 Despite significant inferior vena cava or hepatic venous compression in 65%, hepatic funct

213 kg) kg of whom 4 had occluded inferior vena cava or iliac veins and 2 had previous complex vascular

214 of a roughened catheter into either the vena cava or the aorta.

215 ganglia; (3) occlusion of the inferior vena cava or thoracic aorta; (4) transient ventricular ischae

216 index of collapsibility of the superior vena cava), or increased vasopressor support (right ventricul

217 ridge, crista terminalis, and superior vena cava); or arm 3, standard approach + ablation of left at

218 omy to the inferior vena cava, superior vena cava, or tricuspid annulus or by ablating focally in the

219 suscitation and fluid removal, superior vena cava oxygen saturation, goal-directed, coagulation, immu

220 the lower of the superior and inferior vena cava oxygen saturations.

221 .005), whereas persistent left superior vena cava (P=0.85), ventricular septal defect (P=0.12), and b

222 ium in late frames as compared with the vena cava (percentage injected dose per gram, ctl: 21.4+/-6.1

223 Vena cava pertinent diameters were measured 15-20 mm caudal t

224 l ligation of the suprahepatic inferior vena cava (pIVCL) to simulate congestive hepatopathy-induced

225 hrough partial ligation of the inferior vena cava (pIVCL).

226 a rare case of persistent left superior vena cava (PLSVC) with absent right superior vena cava (RSVC)

227 bject, a congenital left-sided superior vena cava precluded right-sided capture.

228 009 and September 2018 using either the vena cava preserving piggyback technique or caval replacement

229 ients had significantly higher inferior vena cava pressures (15.6 versus 13.7 mm Hg; P=0.007), but on

230 partial-volume correction, the inferior vena cava provides a reliable and reproducible IDIF for Patla

231 The association between vena cava reconstruction technique and stage of postoperative

232 ins controversial whether the choice of vena cava reconstruction technique impacts AKI.

233 he collapsibility index of the inferior vena cava recorded during a deep standardized inspiration pre

234 uter modeling was used to determine the vena cava recovery coefficient.

235 Superior vena cava-related symptoms occur in only 50% of patients with

236 fulness of respiratory variation in the vena cava requires confirmatory studies.

237 recipient abdominal aorta and inferior vena cava, respectively.

238 After catheterization of the inferior vena cava, right atrium, foramen ovale, and left atrium with

239 Because vascular injury in the superior vena cava-right atrium during transvenous lead extraction is

240 l in characterizing ILA in the superior vena cava-right atrium region.

241 Aortic or superior vena cava rim deficiencies were more common in cases than in

242 cava (PLSVC) with absent right superior vena cava (RSVC).

243 The presented IDIF from the vena cava showed a robust determination of CMRGlc using eithe

244 the lowest proportion was for inferior vena cava size [75%]).

245 for (aortic valve was 91% and inferior vena cava size was 58%).

246 ic valve was 96% [highest] and inferior vena cava size was 78% [lowest]) and decreased when nonvisual

247 Hypothetical origin of 5-HMF in Cava sparkling wine is discussed.

248 e structure of a potential ageing marker for Cava sparkling wine.

249 Four different cava sparkling wines were monitored during an accelerate

250 A young woman with a benign superior vena cava stenosis due to a tunneled internal jugular vein di

251 bearing and control mice in an inferior vena cava stenosis model.

252 produced a thrombus 48 h after inferior vena cava stenosis whereas 90% of wild-type mice did.

253 estricted-flow model of murine inferior vena cava stenosis.

254 h at the junction of the right superior vena cava, sulcus terminalis, and RA free wall, corresponding

255 m the lateral atriotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or by abl

256 of the common wall between the superior vena cava (SVC) and the right upper pulmonary vein (RUPV), wh

257 origin, those arising from the superior vena cava (SVC) can precipitate atrial fibrillation (AF).

258 Biatrial drainage of the right superior vena cava (SVC) is a rare form of interatrial shunting that c

259 PURPOSE OF REVIEW: Superior vena cava (SVC) is one of the most important nonpulmonary vei

260 of durable pulmonary vein and superior vena cava (SVC) isolation between radiofrequency ablation and

261 ate the causes and symptoms of superior vena cava (SVC) obstruction or occlusion and report on the lo

262 Superior vena cava (SVC) tears are one of the most lethal complication

263 veins of the thorax including superior vena cava (SVC), brachiocephalic (BCV), subclavian (SCV) and

264 om vascular obstruction of the superior vena cava (SVC).

265 Specifically, superior vena cava syndrome may warrant radiation, chemotherapy, vascu

266 Superior vena cava syndrome was more common in the non-cardiac surgica

267 epartment with symptoms of the superior vena cava syndrome.

268 o aorto-iliac/visceral arteries and the vena cava (temporal resolution, five images per second; and s

269 slope was significantly higher for the vena cava than atrial IDIF (mL/g/min, ctl: 0.11+/-0.02 vs. 0.

270 incipal discharge diagnosis of inferior vena cava thrombosis (International Classification of Disease

271 Vena cava thrombosis can represent a surgical challenge in th

272 the treatment of patients with inferior vena cava thrombosis in the United States.

273 ysis (CDT) in the treatment of inferior vena cava thrombosis is unknown.

274 ng 2674 patients admitted with inferior vena cava thrombosis, 718 (26.9%) underwent CDT.

275 included filter-related acute inferior vena cava thrombosis, chronic inferior vena cava occlusion, a

276 diopulmonary bypass because of extended vena cava thrombosis; in 2 patients, a simultaneous sternotom

277 he right or left lung into the inferior vena cava, through drainage into the hepatic vein, right atri

278 The vena cava time-activity curve is therefore a minimally invasi

279 n of a balloon catheter in the inferior vena cava to identify the lower limit of cerebral autoregulat

280 positioned in the retrohepatic inferior vena cava to shunt hepatic venous effluent through an activat

281 Puncture through the inferior vena cava to the pulmonary venous atrium may be an effective

282 urgical crossing from a donor (superior vena cava) to a recipient (PA) vessel and endovascular stent-

283 Mouse inferior vena cava-to-carotid interposition isografts were completed u

284 ient's HV confluence, and in 3 cases, a vena cava triangulation was necessary; 6 MSUD grafts required

285 nd collapsibility index of the inferior vena cava under a deep standardized inspiration using transth

286 cipient hepatectomy rendered the native vena cava unsalvageable.

287 hagus was deflected toward the inferior vena cava using an esophageal deviation balloon, and ablation

288 ion, mitral regurgitation, and inferior vena cava variability) and correlated abnormalities in select

289 ecruitment of platelets to the inferior vena cava wall after DVT induction were reduced in MC-deficie

290 adder with abdominal aorta and inferior vena cava was isolated and orthotopically sutured to the reci

291 lus empirical isolation of the superior vena cava was performed in all.

292 In addition, the donor vena cava was too short to bridge the caval defect for interp

293 the catheter, access vein, and cranial vena cava were dissected, removed en bloc, and fixed in forma

294 ft atrium, coronary sinus, and superior vena cava were targeted for ablation.

295 pulmonary veins, including the superior vena cava, were successfully isolated.

296 nment defects, and interrupted inferior vena cava with azygos continuation.

297 gallbladder and an interrupted inferior vena cava with azygous continuation.

298 nd the percent collapse of the inferior vena cava with inspiration (collapsibility index) by ultrasou

299 onic indwelling CVC in the low superior vena cava with thrombus in situ was established after feasibi

300 a flattened right lobar portal vein and vena cava without any visible active bleeding.